Your browser doesn't support javascript.
loading
Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine.
Aguirre, Andrew J; Nowak, Jonathan A; Camarda, Nicholas D; Moffitt, Richard A; Ghazani, Arezou A; Hazar-Rethinam, Mehlika; Raghavan, Srivatsan; Kim, Jaegil; Brais, Lauren K; Ragon, Dorisanne; Welch, Marisa W; Reilly, Emma; McCabe, Devin; Marini, Lori; Anderka, Kristin; Helvie, Karla; Oliver, Nelly; Babic, Ana; Da Silva, Annacarolina; Nadres, Brandon; Van Seventer, Emily E; Shahzade, Heather A; St Pierre, Joseph P; Burke, Kelly P; Clancy, Thomas; Cleary, James M; Doyle, Leona A; Jajoo, Kunal; McCleary, Nadine J; Meyerhardt, Jeffrey A; Murphy, Janet E; Ng, Kimmie; Patel, Anuj K; Perez, Kimberly; Rosenthal, Michael H; Rubinson, Douglas A; Ryou, Marvin; Shapiro, Geoffrey I; Sicinska, Ewa; Silverman, Stuart G; Nagy, Rebecca J; Lanman, Richard B; Knoerzer, Deborah; Welsch, Dean J; Yurgelun, Matthew B; Fuchs, Charles S; Garraway, Levi A; Getz, Gad; Hornick, Jason L; Johnson, Bruce E.
Afiliación
  • Aguirre AJ; Dana-Farber Cancer Institute, Boston, Massachusetts. andrew_aguirre@dfci.harvard.edu carter.scott@jimmy.harvard.edu brian_wolpin@dfci.harvard.edu.
  • Nowak JA; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Camarda ND; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Moffitt RA; Harvard Medical School, Boston, Massachusetts.
  • Ghazani AA; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Hazar-Rethinam M; Harvard Medical School, Boston, Massachusetts.
  • Raghavan S; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Kim J; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Brais LK; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Ragon D; Joint Center for Cancer Precision Medicine, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts.
  • Welch MW; Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Reilly E; Department of Biomedical Informatics, Department of Pathology, Stony Brook University, Stony Brook, New York.
  • McCabe D; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Marini L; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Anderka K; Joint Center for Cancer Precision Medicine, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts.
  • Helvie K; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Oliver N; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Babic A; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Da Silva A; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Nadres B; Harvard Medical School, Boston, Massachusetts.
  • Van Seventer EE; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Shahzade HA; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • St Pierre JP; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Burke KP; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Clancy T; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Cleary JM; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Doyle LA; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Jajoo K; Joint Center for Cancer Precision Medicine, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts.
  • McCleary NJ; Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Meyerhardt JA; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Murphy JE; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Ng K; Joint Center for Cancer Precision Medicine, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts.
  • Patel AK; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Perez K; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Rosenthal MH; Joint Center for Cancer Precision Medicine, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts.
  • Rubinson DA; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Ryou M; Joint Center for Cancer Precision Medicine, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts.
  • Shapiro GI; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Sicinska E; Harvard Medical School, Boston, Massachusetts.
  • Silverman SG; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Nagy RJ; Harvard Medical School, Boston, Massachusetts.
  • Lanman RB; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Knoerzer D; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Welsch DJ; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Yurgelun MB; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Fuchs CS; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Garraway LA; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Getz G; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Hornick JL; Harvard Medical School, Boston, Massachusetts.
  • Johnson BE; Dana-Farber Cancer Institute, Boston, Massachusetts.
Cancer Discov ; 8(9): 1096-1111, 2018 09.
Article en En | MEDLINE | ID: mdl-29903880
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Variación Genética / Perfilación de la Expresión Génica / Carcinoma Ductal Pancreático / Genómica Tipo de estudio: Guideline Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Discov Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Variación Genética / Perfilación de la Expresión Génica / Carcinoma Ductal Pancreático / Genómica Tipo de estudio: Guideline Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Discov Año: 2018 Tipo del documento: Article